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Background
Resveratrol, a plant-derived polyphenol, found in red
wine and other food products, is reported to possess
chemotherapeutic properties in several cancers. We
wanted to investigate the molecular mechanisms of
resveratrol-induced cell cycle arrest and apoptosis as well
as the impact of resveratrol on NAMPT (Nicotinamide
phosphoribosyltransferase) and SIRT1 protein func-
tion and asked whether there are differences in
hepatocarcinoma cells and non-cancerous primary
human hepatocytes.
Materials and methods
HepG2 cells (p53+/+), Hep3B cells (p53-/-) and primary
hepatocytes cultured from non-cancerous human liver
tissues were used. Intracellular protein levels of NAMPT,
SIRT1, acetylated p53 (K382), phosphorylated p53
(Ser15) and caspase-3 were analyzed by Western Blot
whereas extracellular NAMPT (eNAMPT) was measured
by eNAMPT ELISA. NAMPT enzymatic activity was
quantified using 14C-labeled nicotinamide. Intracellular
NAD levels were measured by HPLC-Analysis. SIRT1
overexpression studies were performed using pECE-Flag
SIRT1 plasmid via electroporation.
Results
Hepatocarcinoma cells expressed higher levels of SIRT1
and lower amounts of NAMPT compared to primary
human hepatocytes. However, basal NAMPT enzymatic
activity in HepG2 cells was higher than in primary hepato-
cytes. In hepatocarcinoma cells, resveratrol led to cell
cycle arrest by activation of p53 and increased expression
of p21. Induction of apoptosis in hepatocarcinoma cells
was p53-independent and mediated by activation of
caspase-3. In contrast, human hepatocytes showed no
signs of apoptosis after resveratrol exposure. We further
revealed that NAMPT activity was affected by resveratrol
and was oppositely regulated in hepatocarcinoma
cells (-39%) and primary human hepatocytes (+65%).
Acetylation of the tumor suppressor p53 (K382), a major
target site of SIRT1 deacetylation, was strongly increased
in resveratrol-treated HepG2 cells (13.4-fold) suggesting a
SIRT1 inhibition. Resveratrol also induced NAMPT
release from hepatocarcinoma cells which was associated
with increased NAMPT mRNA expression. This effect
was absent in primary hepatocytes where resveratrol was
shown to function as NAMPT and SIRT1 activator.
Moreover, inhibition of NAMPT and SIRT1 activity, by
FK866 or by EX527, led to increased acetylation and
transcriptional activity of p53 and induced apoptosis.
Furthermore, a SIRT1 overexpression significantly
decreased p53 hyperacetylation and resveratrol-induced
NAMPT release as well as S-phase arrest in HepG2
cells. However, resveratrol-induced apoptosis was not
abrogated after SIRT1 overexpression.
Conclusion
Our study revealed that resveratrol selectively induced
p53-independent cell death in hepatocarcinoma cells and
differentially regulated NAMPT and SIRT1 in cancer cells
and non-cancerous cells. Our data give evidence that in
contrast to normal hepatocytes, resveratrol does not act as
a NAMPT and SIRT1 activator in hepatocarcinoma cells.
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